Convatec Group PLC (LON:CTEC) Stock Has Consensus Price Target of GBX 305.44 According to Analysts

Key Points

• Analysts remain broadly positive: Convatec Group has a “Moderate Buy” consensus from nine brokers, with eight buy ratings and one hold. The average 12-month price target is GBX 305.44.
• Recent broker targets range from GBX 270 to GBX 335, including buy or outperform ratings from Deutsche Bank, Jefferies, RBC, Berenberg, and Peel Hunt.
• The stock opened at GBX 212, versus a 52-week range of GBX 193 to GBX 259.30. Insider Tobias Hestler also purchased 50,000 shares at GBX 226 each, valued at £113,000.

Shares of Convatec Group PLC (LON:CTEC - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is GBX 305.44.

A number of brokerages recently commented on CTEC. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 315 target price on shares of Convatec Group in a report on Wednesday, August 5th. Jefferies Financial Group reissued a "buy" rating and set a GBX 300 price target on shares of Convatec Group in a research report on Wednesday, August 5th. Royal Bank Of Canada reissued an "outperform" rating and issued a GBX 315 price objective on shares of Convatec Group in a research note on Monday, August 3rd. Berenberg Bank dropped their price objective on shares of Convatec Group from GBX 340 to GBX 335 and set a "buy" rating for the company in a report on Friday, September 11th. Finally, Peel Hunt reaffirmed an "add" rating and set a GBX 270 target price on shares of Convatec Group in a research note on Tuesday, August 4th.

Convatec Group Stock Performance

CTEC opened at GBX 212 on Monday. Convatec Group has a 52 week low of GBX 193 and a 52 week high of GBX 259.30. The company has a quick ratio of 0.96, a current ratio of 1.93 and a debt-to-equity ratio of 121.83. The business has a fifty day simple moving average of GBX 223.91 and a 200-day simple moving average of GBX 218.55. The firm has a market cap of £4.12 billion, a P/E ratio of 34.19, a P/E/G ratio of 0.93 and a beta of 0.77.

Insider Buying and Selling

In other news, insider Tobias Hestler bought 50,000 shares of Convatec Group stock in a transaction dated Thursday, August 6th. The stock was acquired at an average cost of GBX 226 per share, with a total value of £113,000. 0.98% of the stock is owned by corporate insiders.

Convatec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.